GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton Dickinson & Co (BSP:B1DX34) » Definitions » Forward PE Ratio

Becton Dickinson (BSP:B1DX34) Forward PE Ratio

: 17.01 (As of Today)
View and export this data going back to 2020. Start your Free Trial

Becton Dickinson's Forward PE Ratio for today is 17.01.

Becton Dickinson's PE Ratio without NRI for today is 25.18.

Becton Dickinson's PE Ratio for today is 55.25.


Becton Dickinson Forward PE Ratio Historical Data

The historical data trend for Becton Dickinson's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton Dickinson Annual Data
Trend 2020-12 2021-12 2022-12 2023-12 2024-04
Forward PE Ratio
19.88 20.37 18.90 17.09 17.48

Becton Dickinson Quarterly Data
2020-03 2020-06 2020-09 2020-12 2021-03 2021-06 2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2023-06 2023-09 2023-12 2024-03
Forward PE Ratio 3.72 4.13 3.54 19.88 18.55 18.90 19.80 20.37 21.01 16.34 17.79 18.90 20.16 18.69 19.72 17.09 17.33

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Becton Dickinson's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Becton Dickinson Forward PE Ratio Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Becton Dickinson's Forward PE Ratio falls into.



Becton Dickinson Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Becton Dickinson  (BSP:B1DX34) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Becton Dickinson Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Becton Dickinson's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Becton Dickinson (BSP:B1DX34) Business Description

Address
1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of estimated 2023 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.

Becton Dickinson (BSP:B1DX34) Headlines

No Headlines